Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by naimarantzon Jan 24, 2015 1:37pm
198 Views
Post# 23359371

RE:RE:IS THERE A CONNECTION HERE?

RE:RE:IS THERE A CONNECTION HERE?Freedom, perhaps the reason why nobody answers you questions is because you have proven to be soft basher who resorts to name calling and no answer is ever good enough. You have told people here to listen to Iscfa and yet he posted there will be "no news releases for building inventory" of which we had that very news release within 24 hours of his bash. He also said "There will be no news releases for hiring sales people and winning pharmacy accounts".....!!!? He should probably go back to pumping KEK like he did just before the 30-1 rollback. Face it, you and Iscfa are seriously overstretched in the credibility department. You both seem to show up around the same time professing some problem or other. The fact is that 15-16 shareholders own 40% of the shares and the rest are smaller shareholders. Its obvious you are both shorting the stock and it would be very wise to drop your act and cover.
freedom45 wrote: No one has attempted to answer my questions of yesterday.
Lets start calling NPH what they really are, (IMO) owned by the Fabio Group of Companies. NPH uses their phone and fax numbers and the relationship dates back to ALDA.

 


Corporate Milestones

 
September 21, 2012

Canagen Pharmaceuticals Inc. out-licenses its first pharmaceutical product to Alda Pharmaceuticals Corp.

September 19, 2012

Fazio Corporation Inc. is established in Guyana.

September 13, 2012

The Fazio Group acquires controlling shares of TSX-V and NASDAQ OTC listed Alda Pharmaceuticals Corp.

December 8, 2011

Fazio Corporation Limited achieves a milestone of total sales of 3 million tonnes of Sulphur to S.E. Asia.

April 17, 2011

Fazio Corporation Limited finalizes the purchase/sale agreement of 1,260,000 metric tonnes of iron ore from Mexico to Henan, China.

August 18, 2007

The Fazio Group invests in publicly traded (CNSX and O3X) Ona Power Corp, which owns and operates a 2 x 60MW coal-fired power plant and project in Hunan Province, China.

May 9, 2003

The Fazio Group’s Canagen Pharmaceuticals Corporation establishes its Sino-Foreign Joint venture Company with Haier Group’s Qingdao Haier Pharmaceutical Co., Ltd. with investment of US$ 12 million.

August 2, 2001

Canagen Pharmaceuticals Inc. is established.



Bullboard Posts